3'-Fluoro-4'-(4-oxo-2-propyl-4,5-dihydro-imidazo[4,5-c]pyridin-3-ylmethyl)-biphenyl-2-sulfonic acid tert-butylamide | 1025819-15-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3'-Fluoro-4'-(4-oxo-2-propyl-4,5-dihydro-imidazo[4,5-c]pyridin-3-ylmethyl)-biphenyl-2-sulfonic acid tert-butylamide
• 英文别名: N-tert-butyl-2-[3-fluoro-4-[(4-oxo-2-propyl-5H-imidazo[4,5-c]pyridin-3-yl)methyl]phenyl]benzenesulfonamide
• CAS: 1025819-15-1
• 化学式: C₂₆H₂₉FN₄O₃S
• 分子量: 496.606
• InChiKey: MNJBMTMPYQZCHA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  102
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3'-Fluoro-4'-(4-oxo-2-propyl-4,5-dihydro-imidazo[4,5-c]pyridin-3-ylmethyl)-biphenyl-2-sulfonic acid tert-butylamide 在 4-二甲氨基吡啶 、 potassium tert-butylate 、 三氟乙酸 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 66.0h， 生成 N-Butyl-2-{3-[3-fluoro-2'-(3-phenyl-propionylsulfamoyl)-biphenyl-4-ylmethyl]-4-oxo-2-propyl-3,4-dihydro-imidazo[4,5-c]pyridin-5-yl}-acetamide
  参考文献：
  名称：

  Novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridines. Potent angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes

  摘要：

  The synthesis and pharmacological activity of balanced high affinity non-peptide angiotensin II antagonists of the AT(1) and AT(2) subtype receptors have been presented. A series of previously prepared AT(1) selective 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridines were modified at four different positions in order to increase the AT(2) binding affinity by maintaining the nanomolar activity for the AT(1) receptor. The targeted AT(2)/AT(1) IC50 binding ratio of similar to 1 was achieved with a number of compounds possessing a small alkyl chain at C-2, different acetamide groups at N-5 and a 3-fluoro and 2'-carboxamidosulfonyl substituent at the biphenylmethyl moiety. These modifications led to analogue 12s, which exhibited an AT(2)/AT(1) ratio of 0.74, a subnanomolar AT(1) antagonistic potency (0.18 nM) and a high metabolic stability in rat and monkey liver microsomes in vitro. After oral administration of 3 mg/kg to cynomolgus monkeys, EMD 90423 (potassium salt of 12s) demonstrated good efficacy and a long duration of action as an antihypertensive agent.

  DOI：

  10.1016/s0223-5234(97)84011-1
• 作为产物：
  描述：

  4H-咪唑并[4,5-c]吡啶-4-酮,1,5-二氢-2-丙基- 、 [3-Fluoro-2'-(N-t-butylsulfamoyl)biphenyl-4-yl]methyl Bromide 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 3'-Fluoro-4'-(4-oxo-2-propyl-4,5-dihydro-imidazo[4,5-c]pyridin-3-ylmethyl)-biphenyl-2-sulfonic acid tert-butylamide
  参考文献：
  名称：

  Novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridines. Potent angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes

  摘要：

  The synthesis and pharmacological activity of balanced high affinity non-peptide angiotensin II antagonists of the AT(1) and AT(2) subtype receptors have been presented. A series of previously prepared AT(1) selective 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridines were modified at four different positions in order to increase the AT(2) binding affinity by maintaining the nanomolar activity for the AT(1) receptor. The targeted AT(2)/AT(1) IC50 binding ratio of similar to 1 was achieved with a number of compounds possessing a small alkyl chain at C-2, different acetamide groups at N-5 and a 3-fluoro and 2'-carboxamidosulfonyl substituent at the biphenylmethyl moiety. These modifications led to analogue 12s, which exhibited an AT(2)/AT(1) ratio of 0.74, a subnanomolar AT(1) antagonistic potency (0.18 nM) and a high metabolic stability in rat and monkey liver microsomes in vitro. After oral administration of 3 mg/kg to cynomolgus monkeys, EMD 90423 (potassium salt of 12s) demonstrated good efficacy and a long duration of action as an antihypertensive agent.

  DOI：

  10.1016/s0223-5234(97)84011-1